GlassScriptPhysician profile
Victoria Cornish
NPI 1184607533
$1,570.68
in general payments reported to CMS, 2019-2025
21 companies · $159 in 2025
The $159 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $237 · 2022: $683 · 2023: $401 · 2024: $91.33 · 2025: $159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $651.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $651.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $184.50 | 2021-2023 | |
| Astrazeneca Pharmaceuticals LP | $169.95 | 2021-2024 | Airsupra, Fasenra |
| Glaxosmithkline, LLC. | $167.45 | 2021-2023 | Nucala |
| Pharming Healthcare, INC. | $147.20 | 2021-2023 | Ruconest |
| Csl Behring | $124.80 | 2022-2024 | Haegarda |
| Biocryst US Sales Co., LLC | $122.12 | 2022-2023 | Orladeyo |
| Kaleo, INC. | $116.23 | 2021-2023 | Auvi-Q |
| Boston Scientific Corporation | $102.00 | 2025 | Watchman Flx |
| Phadia US INC. | $65.98 | 2021-2023 | Immunocap |
| Genzyme Corporation | $56.20 | 2022-2024 | |
| Regeneron Healthcare Solutions, INC. | $54.75 | 2021-2023 | Dupixent |
| Novartis Pharmaceuticals Corporation | $54.51 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $39.59 | 2022 | |
| Medtronic, INC. | $39.14 | 2023 | Corevalve Evolut R |
| Novo Nordisk INC | $31.90 | 2025 | Ozempic |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $25.02 | 2025 | Invega Sustenna |
| Stryker Corporation | $16.48 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $14.96 | 2024 | Lifevest |
| Hikma Pharmaceuticals USA | $14.24 | 2022 | |
| Pfizer INC. | $13.77 | 2022 | |
| Ambu INC. | $9.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Victoria Cornish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.